Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNMT3L Antisense RNA 1 (DNMT3L-AS1) is a non-coding RNA transcribed from the antisense strand at the DNMT3L locus[3]. DNMT3L itself is a regulatory protein involved in the establishment of DNA methylation patterns, especially during germ cell development, but DNMT3L-AS1 refers to an RNA gene rather than a protein product[6][7]. The protein-coding DNMT3L is important for genomic imprinting, acts as a cofactor for DNA methyltransferases (DNMT3A and DNMT3B), and interacts with chromatin via histone modifications[1][6][7]. Regulatory non-coding RNAs such as DNMT3L-AS1 may potentially modulate the expression or activity of DNMT3L and associated methylation machinery, and similar antisense RNAs have been shown to affect chromatin state and gene regulation[4][5]. However, there is currently no experimental evidence specifically detailing the function, mechanism, or clinical relevance of DNMT3L-AS1[3]. Key contextual notes: - DNMT3L-AS1 should not be confused with the protein DNMT3L, which is highly relevant in epigenetics and gene regulation but is not itself a DNA methyltransferase enzyme[2][6][7]. - The limited available information supports DNMT3L-AS1 as a valid lncRNA nomenclature but does not indicate it is a clinically actionable or well-characterized molecular target. If you require structured data on the protein DNMT3L, which is a widely studied methyltransferase cofactor, please specify; most functional, therapeutic, biological, and disease-association data are available for DNMT3L protein, not for DNMT3L-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNMT3L Antisense RNA 1 (DNMT3L-AS1).